Health & Environmental Research Online (HERO)


Print Feedback Export to File
8396613 
Journal Article 
Behavioural and clinical predictors for Loiasis 
Mischlinger, J; Veletzky, L; Tazemda-Kuitsouc, GB; Pitzinger, P; Matsegui, PB; Gmeiner, M; Lagler, H; Gebru, T; Held, J; Mordmüller, B; Ramharter, M; , 
2018 
UNIV EDINBURGH, GLOBAL HEALTH SOC 
EDINBURGH 
English 
29497506 
WOS:000437678100021 
Loiasis is a vector-borne disease in Central and West Africa. While there is still uncertainty to what extent loiasis is responsible for population morbidity, individuals having both loiasis and onchocerciasis have a high risk of fatal encephalopathy when treatment (ie, ivermectin) for onchocerciasis is given. Therefore it is current policy that communities of high loiasis-burden are excluded from mass drug administration programmes of ivermectin. To address this treatment gap we present diagnostic scores, based on clinical and behavioural predictors that may help to rapidly identify sub-groups with loiasis within high-burden communities.